16 completed, 8 terminated, 1 active not recruiting, 1 recruiting. 10 Phase 2, 9 Phase 3, 7 Phase 1, 4 Not applicable, 2 Early Phase 1.
Follow Insulin, Regular, Human: new trials by email Literature Review of Insulin, Regular, Human trials Research Report on Insulin, Regular, Human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RCT Glargine vs NPH for Treatment of DM in Pregnancy Insulin glargine, insulin NPH - Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Recruiting | Loyola University | 160 | 2024-04-01 | 2024-10-01 |
| Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL) Insulin, Regular, Human, Placebo - Insulin | Phase 1 | Completed | Pennington Biomedical Research Center | 40 | 2021-06-17 | 2023-11-29 |
| A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus ADO09 formulation, Placebo, Symlin® - Type 1 Diabetes Mellitus | Phase 1 | Completed | Adocia | 24 | 2019-01-04 | 2019-04-16 |
| A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus BC Pram Ins, Symlin® and Humulin®, Humalog® - Type 1 Diabetes Mellitus | Phase 1 | Completed | Adocia | 24 | 2018-04-25 | 2019-02-21 |
| A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes Humulin S - Type 2 Diabetes Mellitus With Hypoglycemia | Not applicable | Completed | University of Hull | 50 | 2017-03-01 | 2018-11-01 |
| Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes Insulin, Glucose, Potassium phosphate - Hypoglycemia | Early Phase 1 | Completed | University of Minnesota | 27 | 2016-11-01 | 2021-02-01 |
| Reprometabolic Syndrome Mediates Subfertility in Obesity Insulin, Intralipid, Dextrose - Obesity, Infertility | Not applicable | Active not recruiting | University of Colorado, Denver | 84 | 2016-06-01 | 2026-03-02 |
| A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes U-500R - Diabetes Mellitus, Type 2 | Phase 1 | Terminated | Eli Lilly and Company | 11 | 2016-01-12 | 2023-10-23 |
| Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit Regular-insulin, Lispro-insulin - Hyperglycemia | Phase 4 | Completed | University of Roma La Sapienza | 28 | 2013-03-01 | 2014-06-17 |
| Molecular Regulation of Muscle Glucose Metabolism U100 Humulin, Exercise - Obesity, Type 2 Diabetes Mellitus | Phase 1 | Terminated | Mayo Clinic | 48 | 2012-04-01 | 2017-11-27 |
| Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance Human insulin - Type 2 Diabetes Mellitus | Phase 1 | Completed | Mayo Clinic | 14 | 2012-03-01 | 2013-06-05 |
| The Effects of Hypoglycaemia in People With Type 2 Diabetes Insulin (Humulin S), Euglycaemic Hypoglycaemic Insulin clamp - Type 2 Diabetes Mellitus | Not applicable | Completed | University of Hull | 18 | 2011-11-01 | 2014-08-01 |
| To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies Canakinumab 150 mg, Placebo to Canakinumab - Type 2 Diabetes Mellitus, Impaired Glucose Tolerance | Phase 2 | Completed | Novartis | 246 | 2010-02-01 | 2011-09-05 |
| Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes Humulin, Humalog, Novolog - Diabetes Mellitus, Metabolic Integrity | Phase 3 | Unknown | Global Infusion and Aspiration Systems, LLC | 2000 | 2009-11-01 | 2011-06-22 |
| Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Insulin - Brain Neoplasms, Intracranial Aneurysm | Early Phase 1 | Completed | Northwestern University | 120 | 2009-10-01 | 2019-12-13 |
| Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM) Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20) - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Halozyme Therapeutics | 23 | 2009-07-01 | 2014-08-18 |
| Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20) - Type 1 Diabetes Mellitus | Phase 2 | Completed | Halozyme Therapeutics | 22 | 2008-10-01 | 2019-02-26 |
| Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20 Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20) - Diabetes Mellitus | Phase 1 | Completed | Halozyme Therapeutics | 26 | 2007-12-01 | 2019-02-26 |
| Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating Regular insulin (Humulin), Insulin lispro (Humalog) - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Becton, Dickinson and Company | 30 | 2007-09-01 | 2008-08-22 |
| Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog ) - Diabetes Mellitus | Phase 3 | Terminated | Florida Atlantic University | 300 | 2007-03-01 | 2016-02-03 |
Showing 20 of 28. Sign in to see all of them.
Hypoglycemia (10) · Diabetes Mellitus (9) · Insulin Resistance (9) · Diabetes Mellitus, Type 2 (7) · Diabetes Complications (6) · Diabetes Mellitus, Type 1 (4) · Diabetic Neuropathies (2) · Hyperglycemia (2) · Obesity (2) · Brain Neoplasms (1) · Diabetes, Gestational (1) · Glucose Intolerance (1) · Hyperinsulinism (1) · Infertility (1) · Inflammation (1)
Florida Atlantic University (7) · Halozyme Therapeutics (3) · Adocia (2) · Mayo Clinic (2) · University of Hull (2) · Becton, Dickinson and Company (1) · Eli Lilly and Company (1) · Global Infusion and Aspiration Systems, LLC (1) · King Saud University (1) · Loyola University (1) · Northwestern University (1) · Novartis (1) · Pennington Biomedical Research Center (1) · University of Colorado, Denver (1) · University of Massachusetts, Worcester (1)
United States (21) · Germany (4) · Italy (2) · United Kingdom (2) · Australia (1) · Canada (1) · Finland (1) · India (1) · Saudi Arabia (1)
Betty Tuller, PhD (4) · Betty Tuller, Ph.D (2) · Grit Andersen, MD (2) · Betty Tuller, Ph.D. (1) · Christoph Kapitza, MD (1) · Dhanesh Gupta, MD (1) · Federico Bilotta, MD, PhD (1) · Joana Lopes Perdigao, MD (1) · Khalid A Al-Rubeaan, MD (1) · Lawrence J. Mandarino, PhD (1) · Lawrence Mandarino, PhD (1) · Linda A Morrow, M.D. (1) · Lori Roust, MD (1) · Marcus Hompesch, M.D. (1)
PMID 33931404, PMID 36203210, PMID 19459762, PMID 21273493, PMID 21355716, PMID 22136324, PMID 25466315, PMID 32949593, PMID 33157081, PMID 33742062, PMID 33838870, PMID 33859620, PMID 33879515, PMID 34248840, PMID 34248841, PMID 34426634, PMID 34645474, PMID 34831332, PMID 34926573, PMID 35415885, PMID 36017315, PMID 36499023, PMID 36643727, PMID 38710978, PMID 41712301
R01DK047936 (1), UL1TR001082 (1)